Wai-Kay Seto

#GUTAbstract by Mao et al on "Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study" via bit.ly/3Ls3Y1I Paper: bit.ly/4bSWGyQ @WK_Seto @CheungKaShingM2 @hkumed @HKUniversity

A BIG thanks to this panel of esteemed leaders of our global liver community for drawing attention to the threat of #MAFLD and helping to save lives. Your enthusiasm and support mean the world to us. ❤️ ✅ Join our mission: ➡️ A world in which no one suffers from the consequences of #MAFLD 🌎🌍🌏 #livertwitter #medtwitter

Prevalence of H pylori is decreasing but still affect >40% of the world population. Concerted efforts are needed to further combat the infection and its complications. @kathysleung @hkumed

Can managing hepatitis B be like diabetes? "Shared-care" between primary & specialty care? It works! Has better coverage! & cost-effective! Read the article in @LancetRH_WPac thelancet.com/journals/lanwp… Thanks to @Prof_Lei_Zhang , William Wong, @DrJasonJOng and many others @hkumed

Old-style academic output! Never thought I would be editing an academic book....well here is the first edition! My sincere thanks to my fantastically efficient co-editor Prof Mohammed Eslam of @Sydney_Uni and to the many many contributors! #hepatitis #liver @hkumed

It is my great honour to present the work of our group in #TLM2022 organized by the #AASLD. Learned so much from this meeting and proud of our team #hkumed I treasure the opportunity to physically meet my good friends and experts in the field.

HKUMed has achieved a record ranking of 13th place in the clinical and health subject of the Times Higher Education World University Rankings 2023.

Liver fat and hepatitis B: partners in crime? Generally speaking? Yes perhaps. Always? Not so. Read the meta-analysis from the link below: @HEP_Journal onlinelibrary.wiley.com/share/author/C… @CheungKaShingM2 @loeymak @jamesyyfung @hkumed @TelAvivUni @CUHKMedicine @dukenus @SNUnow

We should aim for better glycemic control among people living with both chronic hepatitis B and type 2 DM. See editorial: doi.org/10.1002/hep.32… ⁦@HEP_Journal⁩ ⁦@WK_Seto⁩ ⁦@DavidLui_HKU⁩ ⁦@jamesyyfung⁩ ⁦@hkumed⁩ doi.org/10.1002/hep.32…

If living with hepatitis B, good diabetes control also protects your liver. Read the Hepatology article: aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10… @loeymak @RexWHHui @leechihopaul @DavidLui_HKU @jamesyyfung @HEP_Journal @hkumed #diabetes #Liver #hbv

Crowdsourcing - digital innovation to promote viral hepatitis testing via social media Thanks to @JosephTucker @WeimingTang3 Read it at @npjDigitalMed #Sec20" target="_blank" rel="nofollow noopener">nature.com/articles/s4174… #DigitalHealth #HBV #HCV #hepatitis #crowdsourcing @sesh_global @hkumed @LSHTM @uncglobalhealth

If a patient with chronic hepatitis B achieves functional cure, there is a biomarker that predicts the uncommon occurrence of liver cancer. Published in Clinical Infectious Diseases. @CIDJournal doi.org/10.1093/cid/ci… #hbv #fibrosis @loeymak @RexWHHui @jamesyyfung @hkumed

The potentials of artificial intelligence in diagnosing liver cancer. A demonstration of interdisciplinary research. #ilc2022 #easl #london #livercancer #ai #DeepLearning @hkumed

Novel magnetic resonance metrics for newly-diagnosed liver cancer. Collaboration between Medicine, Surgery, Radiology and Pathology; @hkumed & HK Sanatorium. #livercancer #mri #fibrosis #fattyliver #hepatitis Read the article at rdcu.be/cJ2F8

Our study shows how fast #Omicron BA.2 can spread academic.oup.com/cid/advance-ar…

New Research: Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction frontiersin.org/articles/10.33… #microbiology

Decision-making during HBV therapeutics @AsanMedicalCtr @hkumed @UofT @q_nationaltaiwa @smu_medical @GileadSciences @KingsCollegeLon @LaStatale Find the full article here:bit.ly/3Bxvx3H

Eliminate viral hepatitis! @MonashUni @xjtuofficial @hkumed @LancetGH

🆕Article in press❕ Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on #HBV genotype and viral antigen levels #OpenAcces at👉bit.ly/3gbG6j6 #LiverTwitter

Always excited with the work of my very good friend👏👏 @Kelvinkwto @hkumed